Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia: Results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)

Míreanna Comhchosúla

• Even “WISE-R?”—an Update on the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation
  le: Barsky, Lili, et al.
  Foilsithe: (2020)
• Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)
  le: Wessel, Timothy R., et al.
  Foilsithe: (2007)
• In Women with Symptoms of Cardiac Ischemia, Non-Obstructive Coronary Arteries, and Microvascular Dysfunction, ACE Inhibition is Associated with Improved Microvascular Function: A Double-blind Randomized Study from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE): ACE-I Improves Microvascular Function in Women
  le: Pauly, Daniel F., et al.
  Foilsithe: (2011)
• Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
  le: Mohandas, Rajesh, et al.
  Foilsithe: (2015)
• Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study
  le: Doyle, Mark, et al.
  Foilsithe: (2011)